Things continue to unravel for Martin Shkreli, best known as the guy whose company bought the rights to a previously affordable, life-saving generic drug, then increased its price by 5,400% overnight. After being arrested last week in an unrelated securities-fraud investigation, the “pharma bro” has lost his spanking-new job as CEO of KaloBios Pharmaceuticals. [More]
Retrophin
One Day After Arrest For Securities Fraud, Turing Pharmaceuticals CEO Martin Shkreli Resigns
By 12.18.15
A day after he was arrested as part of a securities-fraud investigation, Turing Pharmaceuticals CEO Martin Shkreli is no longer the company’s head executive. [More]
